Viewing StudyNCT05939037



Ignite Creation Date: 2024-05-06 @ 7:12 PM
Last Modification Date: 2024-10-26 @ 3:02 PM
Study NCT ID: NCT05939037
Status: RECRUITING
Last Update Posted: 2024-07-15
First Post: 2023-05-23

Brief Title: Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy
Sponsor:
Organization: UMC Utrecht

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 42
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: